Application of wogonin in resisting porcine epidemic diarrhea virus

The invention discloses that wogonin has the effect of resisting the porcine epidemic diarrhea virus (PEDV) for the first time, wogonin can remarkably inhibit internalization, intracellular replication and new mature virion release of the porcine epidemic diarrhea virus by targeting porcine epidemic diarrhea virium-3c-like protease (PEDV-3CLpro), and can also directly and biologically inactivate the porcine epidemic diarrhea virus in vitro, so that the wogonin can be used for preparing medicines for treating the porcine epidemic diarrhea virus. Therefore, wogonin can be used for preparing drugs or feed additives for resisting the porcine epidemic diarrhea virus..

Medienart:

Patent

Erscheinungsjahr:

2023

Erschienen:

2023

Enthalten in:

Europäisches Patentamt - (2023) vom: 28. Apr. Zur Gesamtaufnahme - year:2023

Sprache:

Englisch

Beteiligte Personen:

WANG JIERU [VerfasserIn]
ZENG XIAOYU [VerfasserIn]
YIN LEI [VerfasserIn]
YIN DONGDONG [VerfasserIn]
PAN XIAOCHENG [VerfasserIn]
DAI YIN [VerfasserIn]
SHEN XUEHUAI [VerfasserIn]
ZHAO RUIHONG [VerfasserIn]

Links:

Volltext [kostenfrei]

Themen:

Sonstige Themen:
615
A23K: Feeding-stuffs specially adapted for animals; metho (...)
A61K: Preparations for medical, dental, or toilet purpose (...)
A61P: Specific therapeutic activity of chemical compounds (...)
che
tec

Anmerkungen:

Source: www.epo.org (no modifications made), First posted: 2023-04-28, Last update posted on www.tib.eu: 2023-12-19, Last updated: 2023-12-22

Patentnummer:

CN116019805

Förderinstitution / Projekttitel:

PPN (Katalog-ID):

EPA018806252